Are you working on small molecule or nucleic acid drug discovery in the target validation or hit to lead stage? Learn how DNA-Encoded Library (DEL) technology can be a vital tool to support your research with the experts at HitGen and firsthand experience shared from LabCentral alumni, Paul Chang, CEO/CSO and Lead Founder of ARASE Therapeutics.